ethyl 7-(2,6-dimethoxyphenyl)-7-oxoheptanoate, 97.0%, 2g

N-(4-Hydroxyphenyl)-4-methylbenzenesulfonamide, 97%, 5g

Palmitate d'isopropyle, min 90 %, pour la synthèse, 500 ml, emballage plastique.

N-(3-hydroxyphenyl)-5-methyl-3-isoxazolecarboxamide, 95.0%, 1g

4-(4-chloro-3-nitrobenzoyl)-8-methyl-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 2g

2,2-Dimethyl-4-pentenoic Acid>98.0%(GC)(T)5g

2-Hydroxycyclohepta-2,4,6-trien-1-one, 95.0%, 100g

(5-Chloro-2-propoxyphenyl)boronic acid, 95.0%, 25g

(R)-5-Bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole, 95.0%, 250mg

4-Aminopiperidine-4-carboxylic acid, 95.0%, 1g

N-(3-Bromophenyl)succinimide, 98%, 1g

TERT-BUTYL 3-((TERT-BUTOXYCARBONYL)(METHYL)AMINO)PROPANOATE, 95.0%, 1g

Membrane de dialyse Spectra/Por® 1 à 4 Spectra/Por® 1 - MWCO 6000 à 8000, 50 mm, 30 m, 1 Pièce(s)